5-(2-Fluorophenyl)-1H-Pyrrole-3-Carbaldehyde CAS 881674-56-2 Vonoprazan Fumarate Intermediate Purity ≥99.0%

Tsanangudzo Pfupi

Zita: 5-(2-Fluorophenyl)-1H-Pyrrole-3-Carbaldehyde

CAS: 881674-56-2

Kuchena: ≥99.0%

Chitarisiko: Yero kusvika kuBrown Powder

Pakati peVonoprazan Fumarate (CAS: 1260141-27-2)

Hunhu Hwepamusoro, Kugadzirwa Kwekutengesa

Inquiry: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Tsanangudzo:

Chemical Properties:

Chemical Name 5-(2-Fluorophenyl)-1H-Pyrrole-3-Carbaldehyde
Mashoko anoreva zvakafanana Vonoprazan Fumarate (TAK-438) Yepakati 3
Nhamba yeCAS 881674-56-2
Nhamba yeCAT RF-PI330
Stock Status MuStock, Kugadzirwa Kunokwira Kusvika Matani
Molecular Formula C11H8FNO
Molecular Weight 189.19
Brand Ruifu Chemical

Zvinotsanangurwa:

Item Zvinotsanangurwa
Chitarisiko Yero kusvika kuBrown Powder
Melting Point 122.0~131.0℃
Kuzivikanwa: RT(HPLC) Gadzirisana neReference Standard
Kurasikirwa Pakuomesa ≤0.50%
Residue On Ignition ≤0.50%
Related Substances
Kuchena ≥99.0%
Chero Kusachena Kumwe ≤0.50%
Zvose Zvisina Kuchena ≤1.0%
Test Standard Enterprise Standard
Usage Pakati peVonoprazan Fumarate (TAK-438) (CAS 881681-01-2)

Package & Kuchengeta:

Package: Bhodhoro, Aluminium foil bag, Cardboard dhiramu, 25kg/Drum, kana zvinoenderana nezvinodiwa nemutengi.

Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza, mwando uye tumbuyu.

Zvakanakira:

1

FAQ:

Application:

5-(2-Fluorophenyl) -1H-Pyrrole-3-Carbaldehyde (CAS 881674-56-2) inoshanda sereagent mukugadzirwa kwekugadzirwa kweinoveli pyrrole derivatives se potassium-competitive acid blocker (P-CAB).5-(2-Fluorophenyl)pyrrole-3-Carboxaldehyde ndiyo yepakati yeVonoprazan Fumarate (CAS 1260141-27-2).Vonoprazan fumarate (Takecab®), yakawanikwa uye yakagadziridzwa naTakeda naOtsuka, yakatenderwa nePMDA yekuJapan muna Zvita 2014, uye inoratidzwa mukurapa gastric ulcer, duodenal ulcer uye reflux esophagitis.Vonoprazan fumarate ine nzira itsva yekuita inonzi potassium-competitive acid blockers, iyo inodzivisa kusungwa kwe potassium ions kuH +, K + -ATPase (inozivikanwawo seproton pump) muchikamu chekupedzisira chegastric acid secretion mugastric parietal cells.Vonoprazan haidziviriri basa reNa +, K + -ATPase kunyange pazvikamu 500 nguva dzakakwirira kudarika iyo yeIC50 tsika dzavo pamusoro pegastric H +, K + -ATPase basa.Uyezve, mushonga wacho hauna kukanganiswa negastric secretory state, kusiyana nePPIs.

Nyora meseji yako pano ugotitumira